These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
462 related articles for article (PubMed ID: 25445704)
1. Brusatol provokes a rapid and transient inhibition of Nrf2 signaling and sensitizes mammalian cells to chemical toxicity-implications for therapeutic targeting of Nrf2. Olayanju A; Copple IM; Bryan HK; Edge GT; Sison RL; Wong MW; Lai ZQ; Lin ZX; Dunn K; Sanderson CM; Alghanem AF; Cross MJ; Ellis EC; Ingelman-Sundberg M; Malik HZ; Kitteringham NR; Goldring CE; Park BK Free Radic Biol Med; 2015 Jan; 78():202-12. PubMed ID: 25445704 [TBL] [Abstract][Full Text] [Related]
2. Brusatol enhances the efficacy of chemotherapy by inhibiting the Nrf2-mediated defense mechanism. Ren D; Villeneuve NF; Jiang T; Wu T; Lau A; Toppin HA; Zhang DD Proc Natl Acad Sci U S A; 2011 Jan; 108(4):1433-8. PubMed ID: 21205897 [TBL] [Abstract][Full Text] [Related]
3. The anti-hepatocellular carcinoma effect of Brucea javanica oil in ascitic tumor-bearing mice: The detection of brusatol and its role. Wang T; Dou Y; Lin G; Li Q; Nie J; Chen B; Xie J; Su Z; Zeng H; Chen J; Xie Y Biomed Pharmacother; 2021 Feb; 134():111122. PubMed ID: 33341052 [TBL] [Abstract][Full Text] [Related]
4. Novel role of TRPV2 in promoting the cytotoxicity of H2O2-mediated oxidative stress in human hepatoma cells. Ma W; Li C; Yin S; Liu J; Gao C; Lin Z; Huang R; Huang J; Li Z Free Radic Biol Med; 2015 Dec; 89():1003-13. PubMed ID: 26456053 [TBL] [Abstract][Full Text] [Related]
5. Brusatol improves the efficacy of sorafenib in Huh7 cells via ferroptosis resistance dependent Nrf2 signaling pathway. Liu X; Liu T; Zhou Z; Bian K; Qiu C; Zhang F Biochem Biophys Res Commun; 2024 Nov; 734():150762. PubMed ID: 39353360 [TBL] [Abstract][Full Text] [Related]
6. Glycycoumarin ameliorates alcohol-induced hepatotoxicity via activation of Nrf2 and autophagy. Song X; Yin S; Huo Y; Liang M; Fan L; Ye M; Hu H Free Radic Biol Med; 2015 Dec; 89():135-46. PubMed ID: 26169726 [TBL] [Abstract][Full Text] [Related]
7. Apoptotic activities of brusatol in human non-small cell lung cancer cells: Involvement of ROS-mediated mitochondrial-dependent pathway and inhibition of Nrf2-mediated antioxidant response. Xie J; Lai Z; Zheng X; Liao H; Xian Y; Li Q; Wu J; Ip S; Xie Y; Chen J; Su Z; Lin Z; Yang X Toxicology; 2021 Mar; 451():152680. PubMed ID: 33465425 [TBL] [Abstract][Full Text] [Related]
8. Apigenin sensitizes doxorubicin-resistant hepatocellular carcinoma BEL-7402/ADM cells to doxorubicin via inhibiting PI3K/Akt/Nrf2 pathway. Gao AM; Ke ZP; Wang JN; Yang JY; Chen SY; Chen H Carcinogenesis; 2013 Aug; 34(8):1806-14. PubMed ID: 23563091 [TBL] [Abstract][Full Text] [Related]
9. The hepatotoxic metabolite of acetaminophen directly activates the Keap1-Nrf2 cell defense system. Copple IM; Goldring CE; Jenkins RE; Chia AJ; Randle LE; Hayes JD; Kitteringham NR; Park BK Hepatology; 2008 Oct; 48(4):1292-301. PubMed ID: 18785192 [TBL] [Abstract][Full Text] [Related]
10. Nrf2 inhibition affects cell cycle progression during early mouse embryo development. Lin Y; Sui LC; Wu RH; Ma RJ; Fu HY; Xu JJ; Qiu XH; Chen L J Reprod Dev; 2018 Feb; 64(1):49-55. PubMed ID: 29249781 [TBL] [Abstract][Full Text] [Related]
11. Nrf2 Inhibitor, Brusatol in Combination with Trastuzumab Exerts Synergistic Antitumor Activity in HER2-Positive Cancers by Inhibiting Nrf2/HO-1 and HER2-AKT/ERK1/2 Pathways. Yang Y; Tian Z; Guo R; Ren F Oxid Med Cell Longev; 2020; 2020():9867595. PubMed ID: 32765809 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of Nrf2-mediated glucose metabolism by brusatol synergistically sensitizes acute myeloid leukemia to Ara-C. Cheng C; Yuan F; Chen XP; Zhang W; Zhao XL; Jiang ZP; Zhou HH; Zhou G; Cao S Biomed Pharmacother; 2021 Oct; 142():111652. PubMed ID: 34112534 [TBL] [Abstract][Full Text] [Related]
13. Activation of the Nrf2 response by intrinsic hepatotoxic drugs correlates with suppression of NF-κB activation and sensitizes toward TNFα-induced cytotoxicity. Herpers B; Wink S; Fredriksson L; Di Z; Hendriks G; Vrieling H; de Bont H; van de Water B Arch Toxicol; 2016 May; 90(5):1163-79. PubMed ID: 26026609 [TBL] [Abstract][Full Text] [Related]
14. NRF2 as a determinant of cellular resistance in retinoic acid cytotoxicity. Tan KP; Kosuge K; Yang M; Ito S Free Radic Biol Med; 2008 Dec; 45(12):1663-73. PubMed ID: 18845239 [TBL] [Abstract][Full Text] [Related]
15. Regulation and role of nuclear factor-E2-related factor 2 (Nrf2) in multidrug resistance of hepatocellular carcinoma. Tian B; Lu ZN; Guo XL Chem Biol Interact; 2018 Jan; 280():70-76. PubMed ID: 29223570 [TBL] [Abstract][Full Text] [Related]
16. Dual effects of the Nrf2 inhibitor for inhibition of hepatitis C virus and hepatic cancer cells. Murakami Y; Sugiyama K; Ebinuma H; Nakamoto N; Ojiro K; Chu PS; Taniki N; Saito Y; Teratani T; Koda Y; Suzuki T; Saito K; Fukasawa M; Ikeda M; Kato N; Kanai T; Saito H BMC Cancer; 2018 Jun; 18(1):680. PubMed ID: 29940898 [TBL] [Abstract][Full Text] [Related]
17. Brusatol Enhances the Radiosensitivity of A549 Cells by Promoting ROS Production and Enhancing DNA Damage. Sun X; Wang Q; Wang Y; Du L; Xu C; Liu Q Int J Mol Sci; 2016 Jun; 17(7):. PubMed ID: 27347930 [TBL] [Abstract][Full Text] [Related]
18. Lysophosphatidate signaling stabilizes Nrf2 and increases the expression of genes involved in drug resistance and oxidative stress responses: implications for cancer treatment. Venkatraman G; Benesch MG; Tang X; Dewald J; McMullen TP; Brindley DN FASEB J; 2015 Mar; 29(3):772-85. PubMed ID: 25398768 [TBL] [Abstract][Full Text] [Related]
19. Application of Mass Spectrometry Profiling to Establish Brusatol as an Inhibitor of Global Protein Synthesis. Vartanian S; Ma TP; Lee J; Haverty PM; Kirkpatrick DS; Yu K; Stokoe D Mol Cell Proteomics; 2016 Apr; 15(4):1220-31. PubMed ID: 26711467 [TBL] [Abstract][Full Text] [Related]
20. The toxic effects and possible mechanisms of Brusatol on mouse oocytes. Ma R; Li H; Zhang Y; Lin Y; Qiu X; Xie M; Yao B PLoS One; 2017; 12(5):e0177844. PubMed ID: 28542354 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]